Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “XLP”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Large-scale testing (Phase 3)Enrolling By InvitationNCT05883748
What this trial is testing

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

Who this might be right for
Erythropoietic Protoporphyria
Disc Medicine, Inc 230
Not applicableLooking for participantsNCT07567131
What this trial is testing

Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)

Who this might be right for
Erythropoietic Protoporphyria (EPP)X-Linked Porphyria (XLP)
Portal Therapeutics, Inc. 50
Not applicableUnknownNCT00006056
What this trial is testing

Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders

Who this might be right for
Chediak-Higashi SyndromeGraft Versus Host DiseaseX-Linked Lymphoproliferative Syndrome+3 more
Fairview University Medical Center 40
Not applicableStudy completedNCT01688895
What this trial is testing

Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact

Who this might be right for
Erythropoietic ProtoporphyriaEPPX-Linked Protoporphyria+5 more
Icahn School of Medicine at Mount Sinai 150
Testing effectiveness (Phase 2)Study completedNCT00605657
What this trial is testing

Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS)

Who this might be right for
ALPSHypersplenismLymphadenopathy
Koneti Rao 6
Not applicableStudy completedNCT02979249
What this trial is testing

Oral Iron for Erythropoietic Protoporphyrias

Who this might be right for
Erythropoietic ProtoporphyriaEPPX-linked Protoporphyria+1 more
Icahn School of Medicine at Mount Sinai 16
Not applicableStudy completedNCT04902807
What this trial is testing

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

Who this might be right for
Autoimmune Lymphoproliferative SyndromeAutoimmune CytopeniaAutoimmune Diseases+17 more
Institut National de la Santé Et de la Recherche Médicale, France 325
Not applicableAvailableNCT07603401
What this trial is testing

Expanded Access Program of Bitopertin For Participants With EPP or XLP

Who this might be right for
Erythropoietic Protoporphyria (EPP)X-Linked Protoporphyria (XLP)
Disc Medicine, Inc
Testing effectiveness (Phase 2)Active Not RecruitingNCT04641442
What this trial is testing

Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations

Who this might be right for
NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations
Novartis Pharmaceuticals 17
Early research (Phase 1)Study completedNCT00013689
What this trial is testing

Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome

Who this might be right for
Autoimmune DiseaseLymphoproliferative Disorder
National Institute of Allergy and Infectious Diseases (NIAID) 8
Not applicableStudy completedNCT00068146
What this trial is testing

Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma

Who this might be right for
Lymphoproliferative DisordersLymphoma
National Institute of Allergy and Infectious Diseases (NIAID) 77
Not applicableLooking for participantsNCT04528355
What this trial is testing

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+2 more
Paul Szabolcs 50
Not applicableLooking for participantsNCT06781437
What this trial is testing

Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)

Who this might be right for
Lymphoproliferative Syndrome, AutoimmuneLymphoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 5,500
Testing effectiveness (Phase 2)Study completedNCT00368355
What this trial is testing

T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts

Who this might be right for
Acute Lymphoblastic LeukemiaNon Hodgkins LymphomaMyelodysplastic Syndrome+6 more
Baylor College of Medicine 46
Not applicableLooking for participantsNCT00001350
What this trial is testing

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

Who this might be right for
Benign Lymphoproliferative Disorder
National Institute of Allergy and Infectious Diseases (NIAID) 1,200
Large-scale testing (Phase 3)Study completedNCT04402489
What this trial is testing

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked Protoporphyria

Who this might be right for
EPPXLP
Tanabe Pharma America, Inc. 184
Not applicableWithdrawnNCT01672918
What this trial is testing

Fluorodeoxyglucose Imaging Studies to Detect Lymphoma

Who this might be right for
Autoimmune Lymphoproliferative SyndromeLymphoma
National Institute of Allergy and Infectious Diseases (NIAID)